Status:
COMPLETED
Inflammation and Nutritional Parameters in Hemodialysis Patients Using Reprocessed Dialyzers
Lead Sponsor:
Fresenius Medical Care North America
Conditions:
End Stage Renal Disease
Inflammation
Eligibility:
All Genders
18+ years
Brief Summary
The study is a prospective cohort trial utilizing sequential laboratory results from excess serum obtained from hemodialysis patients (acting as their own controls). The objective of this study is to ...
Detailed Description
The proposed project is an ancillary quality improvement study that intends to prospectively track serum markers of inflammation (C-reactive protein or CRP) and nutrition (pre-albumin) at baseline (wi...
Eligibility Criteria
Inclusion
- Patients undergoing hemodialysis in 48 dialysis units that have been identified as continuing to reuse dialyzers processed with peracetic acid-based disinfectant (Renalin®), as of February 1, 2007.
Exclusion
- Hemodialysis patients not currently reusing reprocessed dialyzers
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT00440908
Start Date
March 1 2007
End Date
December 1 2007
Last Update
May 7 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fresenius Medical Care North America
Waltham, Massachusetts, United States, 02145
2
Fresenius Medical Care North America
Waltham, Massachusetts, United States, 02451